CytomX Therapeutics Inc (NASDAQ:CTMX)
| 1.68 BATS BZX Real-Time Price As of 10:40am ET |  0.00 / 0.00%Today’s Change | 1.17 Today|||52-Week Range 3.02 | +5.00% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $114.1M |
Company Description
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Contact Information
CytomX Therapeutics, Inc. 151 Oyster Point Boulevard South San Francisco California 94080-1913 |
Employees
Shareholders
| Other institutional | 42.60% |
| Individual stakeholders | 24.25% |
| Mutual fund holders | 12.46% |
Top Executives
| Sean A. McCarthy | Chairman, President & Chief Executive Officer |
| Chris Ogden | Chief Financial & Accounting Officer |
| Marcia P. Belvin | Chief Scientific Officer & Senior Vice President |
| Lloyd A. Rowland | Secretary, Compliance Officer & General Counsel |
| Jeffrey Landau | Chief Business Officer, Senior VP & Head-Strategy |
